Related Experiment Video
Updated: Jul 12, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
The Chains of Ferroptosis Interact in the Whole Progression of Atherosclerosis
Xueqi Wan1, Huan Zhang1, Jinfan Tian1
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.
Insights
Ferroptosis, a novel cell death pathway involving iron, impacts cardiovascular diseases like atherosclerosis. Understanding ferroptosis mechanisms offers new therapeutic targets for atherosclerosis progression.
Area of Science:
- Biomedical Science
- Cardiovascular Research
- Cellular Biology
Background:
- Atherosclerosis (AS) is a major cardiovascular disease (CVD) with complex pathogenesis and limited therapeutic options.
- Ferroptosis is a distinct programmed cell death pathway characterized by iron accumulation and lipid peroxidation.
- Ferroptosis plays a role in various cardiovascular conditions, including AS, stroke, and heart failure.
Purpose of the Study:
- To systematically review the initiation and modulation of ferroptosis.
- To summarize the contribution of ferroptosis to the pathology of atherosclerosis.
- To explore ferroptosis as a potential therapeutic target for AS.
Main Methods:
- Literature review of ferroptosis mechanisms and its role in cardiovascular diseases.
- Systematic analysis of molecular pathways involved in ferroptosis.
- Synthesis of current understanding of ferroptosis in the context of atherosclerosis.
Main Results:
- Ferroptosis is characterized by iron overload, redox imbalance, and lipid hydroperoxide accumulation.
- Ferroptosis affects key cardiovascular cells like endothelial cells, VSMCs, and macrophages.
- Ferroptosis is implicated in the inflammatory processes underlying AS.
Conclusions:
- Ferroptosis is a significant contributor to atherosclerosis development and progression.
- Targeting ferroptosis pathways presents a promising therapeutic strategy for managing AS.
- Further research into ferroptosis mechanisms may unveil novel treatments for cardiovascular diseases.
Abstract:
Atherosclerosis (AS), a category of cardiovascular disease (CVD) that can cause other more severe disabilities, increasingly jeopardizes human health. Owing to its imperceptible and chronic symptoms, it is hard to determine the pathogenesis and precise therapeutics for AS. A novel type of programmed cell death called ferroptosis was discovered in recent years that is distinctively different from other traditional cell death pathways in morphological and biochemical aspects. Characterized by iron overload, redox disequilibrium, and accumulation of lipid hydroperoxides (L-OOH), ferroptosis influences endothelial cells, vascular smooth muscle cells (VSMCs), and macrophages, as well as inflammation, partaking in the pathology of many cardiovascular diseases such as atherosclerosis, stroke, ischemia-reperfusion injury, and heart failure. The mechanisms behind ferroptosis are so sophisticated and interwoven that many molecules involved in this procedure are unknown. This review systematically depicts the initiation and modulation of ferroptosis and summarizes the contribution of ferroptosis to AS, which may open a feasible approach for target treatment in the alleviation of AS progression.
Related Concept Videos
Atherosclerosis I: Introduction
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Inflammation
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

